| ITRAX | PACLX | ITRAX / PACLX | |
| Total Expense Ratio | 1.25 | 0.98 | 128% |
| Annual Report Gross Expense Ratio | 1.25 | 1.01 | 124% |
| Fund Existence | 23 years | 22 years | - |
| Gain YTD | -7.741 | 6.499 | -119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.97B | 70.4B | 10% |
| Annual Yield % from dividends | 1.36 | 1.48 | 92% |
| Returns for 1 year | -5.01 | 2.63 | -191% |
| Returns for 3 years | 1.59 | 18.73 | 9% |
| Returns for 5 years | -18.55 | 6.11 | -303% |
| Returns for 10 years | 3.78 | 59.74 | 6% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 17.54 | 0.25 | +1.45% |
| ICON Health and Information Tech Inv | |||
| KLCCX | 8.10 | 0.10 | +1.25% |
| Federated Hermes Kaufmann Large Cap C | |||
| JHTCX | 21.38 | 0.11 | +0.52% |
| JPMorgan Hedged Equity 3 C | |||
| MPGVX | 17.76 | 0.07 | +0.40% |
| Mondrian Global Equity Value | |||
| JVMSX | 31.13 | 0.02 | +0.06% |
| JHancock Disciplined Value Mid Cap R2 | |||